Back
Novo Nordisk AS Stock Price Chart

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
23
NVO
Novo Nordisk AS
Last Price:
$68.14
Seasonality Move:
3.69%
7 Day Trial
ALL ACCESS PASS
$
7

The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
The current trend is relatively stagnant and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.44 | Buy |
20-day SMA: | 65.94 | Buy |
50-day SMA: | 67.71 | Buy |
200-day SMA: | 97.42 | Sell |
8-day EMA: | 66.78 | Buy |
20-day EMA: | 66.23 | Buy |
50-day EMA: | 69.34 | Sell |
200-day EMA: | 89.98 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 53.87 | Buy |
Chaikin Money Flow: | -8100748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.7 - 67.84) | Buy |
Bollinger Bands (100): | (66.51 - 86.17) | Sell |
Novo Nordisk AS Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 68.20 while NVO 8-day simple moving average is 66.44, which is a Buy signal.
-
The stock price of NVO is 68.20 while Novo Nordisk AS 20-day SMA is 65.94, which makes it a Buy.
-
Novo Nordisk AS 50-day simple moving average is 67.71 while NVO share price is 68.20, making it a Buy technically.
-
NVO stock price is 68.20 and Novo Nordisk AS 200-day simple moving average is 97.42, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NVO] share price is $68.20. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
303B
Price in USD:
68.20
Share Volume:
8.9M
Novo Nordisk AS 52-Week Range
52-Week High:
148.15
52-Week Low:
57.00
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 68.20 USD today.
-
Will NVO stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 68.20 while NVO 8-day exponential moving average is 66.78, which is a Buy signal.
-
The stock price of NVO is 68.20 while Novo Nordisk AS 20-day EMA is 66.23, which makes it a Buy.
-
Novo Nordisk AS 50-day exponential moving average is 69.34 while NVO share price is 68.20, making it a Sell technically.
-
NVO stock price is 68.20 and Novo Nordisk AS 200-day simple moving average is 89.98, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.15 per share, an increase this year of $0.85 per share, and an increase next year of $0.68 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Novo Nordisk AS is a Sell
-
Novo Nordisk AS Relative Strength Index (RSI) is 53.87, which suggest Novo Nordisk AS is overbought
-
The Bollinger Bands (25) for Novo Nordisk AS is (61.7 - 67.84), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (66.51 - 86.17), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.